Latest Tomotherapy Stories

Accuray Incorporated's CEO to Speak at Cowen and Company 32nd Annual Healthcare Conference

2012-02-27 07:30:00

SUNNYVALE, Calif., Feb. 27, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that its president and chief executive officer, Euan S. Thomson, Ph.D., is scheduled to present at the Cowen and Company Healthcare Conference in Boston on Tuesday, March 6, 2012 at 8:00 a.m. EST/5:00 a.m. PST. A live webcast of the presentations will be available online from the Investor Relations page of the Company's website at...

Accuray Incorporated to Speak at Citi 2012 Global Health Care Conference

2012-02-15 10:13:00

SUNNYVALE, Calif., Feb. 15, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that its management is scheduled to present at the Citi 2012 Global Health Care Conference in New York City on Tuesday, February 28, 2012 at 11:00 a.m. EST/8:00 a.m. PST. A live webcast of the presentations will be available online from the Investor Relations page of the Company's website at http://www.accuray.com. The webcast replay of...

First Prospective Clinical Trial of Adaptive Radiotherapy for Head & Neck Cancer Patients

2012-02-09 16:54:00

MANHASSET, N.Y., Feb. 9, 2012 /PRNewswire-USNewswire/ -- Researchers led by a senior investigator at Hofstra-North Shore LIJ School of Medicine and The Feinstein Institute for Medical Research have released initial findings from a first-of-a-kind clinical trial in adaptive radiotherapy (ART) for head and neck cancer. The trial, sponsored by the National Cancer Institute, provides evidence that ART may benefit patients with less technical difficulty than previously believed. The...

UC Davis Research Finds Newer Radiation Therapy Technology Improves Patients' Quality Of Life

2012-01-26 13:34:00

Fewer permanent disabilities and other side effects from treatment reported Patients with head and neck cancers who have been treated with newer, more sophisticated radiation therapy technology enjoy a better quality of life than those treated with older radiation therapy equipment, a study by UC Davis researchers has found. The findings, presented today at the Multidisciplinary Head and Neck Cancer Symposium in Phoenix, is the first of its kind to measure long-term quality of life...

Newer Radiation Technology Improves Head And Neck Cancer Patients' Long-Term Quality Of Life

2012-01-26 11:48:09

Patients treated with IMRT for head and neck cancer report an increasingly better quality of life post-treatment when compared to patients receiving other forms of radiation therapy, according to a study presented at the Multidisciplinary Head and Neck Cancer Symposium, sponsored by AHNS, ASCO, ASTRO and SNM. Intensity modulated radiation therapy, or IMRT, is a highly specialized form of external beam radiation therapy that allows the radiation beam to better target and conform to a tumor....

Study Highlights CyberKnife SBRT Benefits for Treatment of Central Lung Tumors

2012-01-26 07:30:00

SUNNYVALE, Calif., Jan. 26, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today publication of a study demonstrating the benefits of the CyberKnife® Robotic Radiosurgery System in treating central lung tumors. Historically, the treatment of central lung tumors using gantry based Stereotactic Body Radiotherapy (SBRT) has been challenging and required a great deal of accuracy to avoid risks of damaging critical...

Accuray Incorporated to Report Financial Results for Second Quarter of Fiscal 2012

2012-01-18 07:30:00

SUNNYVALE, Calif., Jan. 18, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, today announced that it will report results for its second quarter of fiscal year 2012, ended December 31, 2011 on Wednesday, February 8, 2012 after the market closes. A conference call to review the results of its second quarter of fiscal year 2012 will begin at 2:00 p.m. PST/5:00 p.m. EST and will be hosted by Euan S. Thomson, Ph.D., president and chief...

First CyberKnife Robotic Radiosurgery System Goes Live in Mexico

2012-01-17 07:30:00

SUNNYVALE, Calif., Jan. 17, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that CHRISTUS MUGUERZA Hospital Alta Especialidad in Monterrey, Mexico has starting treating patients with the CyberKnife® Robotic Radiosurgery System. CHRISTUS MUGUERZA is the first center in Mexico now offering patients the benefits of the CyberKnife System to treat tumors anywhere in the body. The CyberKnife System is a...

Accuray Surpasses 600 Installations Globally

2012-01-10 07:30:00

SUNNYVALE, Calif., Jan. 10, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today significant momentum in global adoption of its CyberKnife® Robotic Radiosurgery System and TomoTherapy® System, solidifying the company's footprint in the large and growing radiation oncology market. This, along with the company's short- and long-term growth strategy, was presented yesterday by Accuray President and Chief Executive...

Study Highlights CyberKnife Stereotactic Body Radiotherapy (SBRT): Noninvasive Brachytherapy-like Treatment for Prostate Cancer

2012-01-09 07:30:00

SUNNYVALE, Calif., Jan. 9, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, today announced publication of a study describing the clinical outcomes of prostate cancer patients treated with stereotactic body radiotherapy (SBRT) using Accuray's CyberKnife® Robotic Radiosurgery System in a manner that uniquely mimics HDR (high dose rate) brachytherapy dosing within the prostate gland. The University of California--San Francisco (UCSF)...